Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating income | -$115M | -$219M | -$568M | -$436M | -$885M | -$745M |
| Net income | -$119M | -$214M | -$570M | -$408M | -$846M | -$739M |
| EPS (diluted) | -$3.01 | -$5.43 | -$12.75 | -$5.73 | -$9.28 | -$6.86 |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$76.0M | -$146M | -$298M | -$332M | -$582M | -$609M |
| Capital expenditures | $1.10M | $938K | $6.07M | $3.05M | $4.05M | $715K |
| Free cash flow | -$77.1M | -$147M | -$304M | -$335M | -$587M | -$610M |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $82.5M | $76.1M | $205M | $248M | $99.1M | $230M |
| Total assets | — | $142M | $662M | $513M | $615M | $451M |
| Total liabilities | — | $47.4M | $123M | $85.2M | $192M | $399M |
| Shareholders' equity | $16.8M | $34.7M | $539M | $428M | $423M | $52.1M |
| Retained earnings | — | $0.00 | -$91.1M | -$499M | -$1.35B | -$2.08B |
| Shares (wtd avg diluted) | 39.4M | 39.4M | 44.7M | 71.2M | 91.2M | 108M |
Every figure is extracted from Biohaven Ltd.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.